Researchers have determined that a copper compound known for decades may form the basis for a therapy for amyotrophic lateral sclerosis (ALS), or Lou Gehrig’s disease.
In a new study just published in the Journal of Neuroscience, scientists from Australia, the United States (Oregon), and the United Kingdom showed in laboratory animal tests that oral intake of this compound significantly extended the lifespan and improved the locomotor function of transgenic mice that are genetically engineered to develop this debilitating and terminal disease.
In humans, no therapy for ALS has ever been discovered that could extend lifespan more than a few additional months. Researchers in the Linus Pauling Institute at Oregon State University say this approach has the potential to change that, and may have value against Parkinson’s disease as well.
“We believe that with further improvements, and following necessary human clinical trials for safety and efficacy, this could provide a valuable new therapy for ALS and perhaps Parkinson’s disease,” said Joseph Beckman, a distinguished professor of biochemistry and biophysics in the OSU College of Science.
“I’m very optimistic,” said Beckman, who received the 2012 Discovery Award from the OHSU Medical Research Foundation as the leading medical researcher in Oregon.
Read more . . .
The Latest on: Therapy for Lou Gehrig’s disease
[google_news title=”” keyword=”Therapy for Lou Gehrig’s disease” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Therapy for Lou Gehrig’s disease
- FDA's advisory panel recommends approval for an "ultra-rare" ALS drugon March 28, 2023 at 7:27 am
Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease that is also known as Lou Gehrig’s Disease. It results in deterioration of motor n | Drug Discovery And Development ...
- There Is No Cure For ALS, But Coya Therapeutics Might Have The Answer According To A New Clinical Studyon March 28, 2023 at 5:03 am
Coya Therapeutics (NASDAQ: COYA) has just reported proof of concept data from its trial for COYA 302, a new combination drug for treating amyotrophic lateral sclerosis (ALS).
- SHIFRUNS event returns to help fight ALSon March 27, 2023 at 2:24 pm
Look for a sea of purple on Tuesday as skiers and riders take to the slopes for the annual SHIFRUNS event on Vail Mountain. SHIFRUNS challenges participants to ski 20 runs in one day ...
- Parkinson’s Disease Treatment Market Size, Key Insights Based on Product Type, Endues and Regional Demand 2023 to 2031on March 26, 2023 at 11:50 pm
Parkinson’s disease is a disorder of the central nervous system that damage the nerve cell in the brain, which causes dopamine levels to drop, and affects movement, often including tremors, rigidity, ...
- GSK loses bid to keep experts out of upcoming Zantac trialon March 24, 2023 at 7:24 am
GSK (GlaxoSmithKline) logo is seen in this illustration, August 10, 2022. REUTERS/Dado Ruvic/Illustration/ ...
- US FDA panel backs accelerated approval for Biogen's ALS drugon March 23, 2023 at 3:31 pm
A panel of advisers to the U.S. drug regulator voted that data on Biogen Inc's experimental treatment for ALS, also known as Lou Gehrig's disease, shows that the drug could work, potentially paving ...
- FDA staff says Biogen's ALS drug may have a 'clinical benefit' on a rare form of the diseaseon March 20, 2023 at 11:53 am
The FDA staff on Monday said Biogen's investigational ALS drug tofersen may have a "clinical benefit" on a rare and aggressive form of the disease.
- Biogen ALS drug may have treatment effect, FDA staff sayson March 20, 2023 at 11:07 am
Biogen's studies of its drug for a rare form of ALS suggest the drug has a "treatment effect," the Food and Drug Administration's staff said.
- ATP CEO Brad Drewett has Lou Gehrig’s Diseaseon March 19, 2023 at 5:00 pm
MELBOURNE, Australia -- Brad Drewett has been diagnosed with Lou Gehrig's disease, and the ATP World Tour executive chairman and president is planning to step down once a successor is found.
- Kansas family dealing with ALS treatment costs needs help with unemployment claimon March 16, 2023 at 6:18 pm
AND I STILL CAN’T GET ANY HELP. IT’S HARDER SINCE HIS WIFE HAS ALS. LOU GEHRIG’S DISEASE. SHE JUST WENT TO THE ICU WEDNESDAY, AND CAVELL DOESN’T KNOW HOW HE CAN PAY. WE JUST NEED HELP. I MEAN, SO ...
via Bing News
